Ampreloxetine Funding (Tables)

12 Months Ended

Dec. 31, 2024

Ampreloxetine Funding.

Schedule of Changes to the Contingent liability

(In thousands)
Balance at December 31, 2023	$	27,788
Non-cash interest expense accretion		2,546
Balance at December 31, 2024	$	30,334